Neurocrine Biosciences Inc
Closed
SectorHealthcare
170.25 -0.88
Overview
Share price change
24h
Min
169.01
Max
171.5
Income | 44M 198M |
|---|---|
Sales | 9M 815M |
P/E Sector Avg | 27.248 60.149 |
EPS | 1.94 |
Profit margin | 24.297 |
Employees | 2,000 |
EBITDA | 19M 254M |
Recommendations | Strong Buy |
|---|---|
12 Months Forecast | +16.87% upside |
Next Earnings | 30 Jul 2026 |
|---|
Market Cap | 4.3B 18B |
|---|---|
Previous open | 171.13 |
Previous close | 170.25 |
News Sentiment
By Acuity
50%
50%
155 / 340 Healthcare
Neurocrine Biosciences Inc Chart
Past performance is not a reliable indicator of future results.
Related News
Peer Comparison
Price change
Neurocrine Biosciences Inc Forecast
Price Target
By TipRanks
12 Months Forecast
Average 199.7 USD 16.87%
High 246 USD
Low 155 USD
Based on 24 Wall Street analysts offering 12 month price targets forNeurocrine Biosciences Inc - Dist in the last 3 months.
Sentiment
By Acuity
News Sentiment
Neutral
Volatility
Below average
News Volume (RCV)
Below average
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$